A drug discovery company that uses single cell RNA sequencing technology to discover unique biological insights that were not identifiable otherwise. It combines proprietary scRNA methods and machine learning platform to identify underlining pathogenesis at a individual cell level.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $148M
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | S32 | s32.com |
| - | Section 32 | section32.... |
| - | Fast Track... | us.fasttra... |
| - | Catalio Ca... | cataliocap... |
| - | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.03.2022 | - | $83M | - |
| 15.05.2018 | Series A | $65M | - |
Mentions in press and media 5
| Date | Title | Description |
| 24.03.2022 | Celsius turns up the heat with lead drug selection, $83M financing | The temperature is rising at Celsius Therapeutics as the precision-medicine-focused biotech picks a lead candidate and reels in $83 million in funding. Celsius has now picked its first clinical candidate, an antibody treatment for inflammat... |
| 03.12.2020 | elluminate® Clinical Data Platform from eClinical Solutions Selected by Celsius Therapeutics to Speed Insights & Value of Clinical Data | “The elluminate platform and Mapper application are designed to help life sciences companies like Celsius unlock the value of their data faster, replacing manual processes with automated insights,” said Raj Indupuri, eClinical Solutions Co-... |
| 15.05.2018 | Celsius Therapeutics Launches with $65 Million in Series A Financing | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer, launched today with a $65 million Series A financing led by Third Ro... |
| 15.05.2018 | Term Sheet — Tuesday, May 15 | ALL BETS ARE ON Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop In a 6-3 ruling, The Supreme Court cleared the way for states to legalize sports betting, striking down a 1992 federal l... |
| 15.05.2018 | Celsius Therapeutics Raises $65M in Series A Financing | Celsius Therapeutics, a Cambridge, MA-based company translating single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer, launched with a $65m Series A financing. The round was led by Third Rock Ventures w... |